Basel scores tenth place in quality of living ranking
Basel among the ten cities with the highest quality of living in the world, according to a survey from the consultancy group Mercer. The city ranking can help companies decide where to open a new office.
Expats have given Basel some of the highest possible scores, with the city coming in tenth place in Mercer’s global quality of living ranking. Vienna came in first place, followed by Zurich. Third place was shared among Auckland, Munich and Vancouver.
Two other Swiss cities made it into the top 15, with Geneva in 8th and Bern in 14th.
The lowest ranked cities were Yemen’s capital Sanaa (229), the capital of the Central African Republic, Bangui (230) and Iraq’s capital Baghdad (231) at the bottom of the list.
Mercer conducts a survey each year with expatriates on how they evaluate quality of living in 450 cities throughout the world, 231 of which are included in the ranking. The living conditions are analyzed according to 39 categories, including health services, education and transportation, as well as other public services.
The annual city ranking also helps multinational companies compare different locations, which can be useful when considering where to open a new office, writes Mercer in a statement.
Basel was included in the Mercer city ranking for the first time in 2017, when it also made it into the prestigious top ten.
Share this article
You might also be interested in
Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss government has just signed a supply contract with the US company for 4.5 million doses of the vaccine.Read More
The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.Read More
The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.Read More
The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.Read More
Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the Basel Area, as revealed by an Interpharma report. However, the region also shines in an international comparison. Interpharma CEO René Buholzer regards it as “probably the most productive life sciences location in the world”.Read More
Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros and additional equity capital financing from a European fund with the aim of accelerating innovation. The company is developing the world’s fastest test against antibiotic resistance.Read More